7*24 Hotline：
Beijing Tongrentang Co., Ltd. (hereinafter referred to as "the company") is the first listed company of Tongrentang Group. The company was established in 1997 and listed on Shanghai Stock Exchange. After more than 20 years of development, the scale of the company has gradually expanded, and the registered capital has reached 1.371 billion yuan. In 2012, according to the overall deployment of the group company, Beijing Tongrentang Co., Ltd. (Group) was established on the basis of the joint stock company.
The company is a modern enterprise integrating production, sales, scientific research and distribution, with a total area of about one million square meters. In Daxing, Changping, Tongzhou and Yizhuang, there are modern production bases (Daxing Branch, Yizhuang branch, North Branch, Tongzhou branch, pharmaceutical liquor factory and pretreatment branch), one business unit (business branch), one research unit (Scientific Research Institute) and one distribution unit (distribution center). It has many subsidiaries, such as natural medicine company, Jilin ginseng company, Lingchuan dangshen company, Inner Mongolia traditional Chinese Medicine Development Co., Ltd., Anguo traditional Chinese medicine processing company, Anguo traditional Chinese medicine logistics distribution company, etc.
The company has 30 production lines, 530 product approval numbers, 250 perennial varieties, covering 23 product formulations, such as pills, powders, liquor and capsules, oral liquid, dropping pills, etc., forming a cardio cerebrovascular series represented by Angong Niuhuang pills, Tongren Niuhuang Qingxin pills, Tongren Dahuoluo pills, and Tongren Wuji Baifeng pills and Kunbao pills There are 12 different series of varieties, such as Guogong liquor and Guci Xiaotong liquor. We have independently researched and developed a new Chinese medicine, Morinda officinalis oligosaccharide capsule, which has opened a new situation in the field of Chinese medicine in the treatment of mild depression.
In order to meet the increasing market demand and improve the labor rate, in recent years, on the basis of strengthening industrial and commercial communication and scientific production scheduling, the company has vigorously promoted the process of production mechanization. It has successively carried out the R & D and promotion of honey pill automatic wax dipping machine, shell buckle machine, gold stamp transfer printing technology, cellophane automatic packaging machine and other projects, and introduced the bag packaging production line of "pill filling technology", So that the company's traditional Chinese medicine automation production level to a new level. Among them, the wax dipping machine application project won the second prize of the 27th Beijing enterprise management modernization innovation achievement.
In the face of the new normal of economic development, combined with the coordinated development planning of Beijing Tianjin Hebei, the non capital function relief and the actual development of enterprises, the joint stock company has invested in the establishment of modern industrial parks in Daxing District pharmaceutical and biological industry base in Beijing and Anguo City in Hebei Province, respectively, in order to meet the development requirements of the company in the 13th five year plan. Daxing Industrial Park project has been completed and put into use in 2016, Anguo Industrial Park Chinese herbal medicine processing project was completed in November 2015, and officially put into operation in 2016 through the new GMP certification.
In recent years, the company has continuously improved its management level, product quality, service quality, operation quality and asset quality through changing concepts, consolidating foundation, scientific and technological innovation and other measures, and steadily improved its economic benefits.
oil wellhead